The pan-Canadian Pharmaceutical Alliance’s (pCPA) Board of Directors is excited to announce that Douglas Clark will become the first CEO of the newly incorporated organization, effective September 11, 2023.
The pan-Canadian Pharmaceutical Alliance is pleased to announce that our transition to a stand-alone organization is now complete.
The pCPA is accepting feedback regarding the development of a set of principles and conditions that will inform the negotiation process and potential product listing agreements for any drug products that follow the CADTH time-limited recommendation pathway.
The pCPA continues the transition to a stand-alone organization with the expectation that this process will be completed in the summer.
The pan-Canadian Pharmaceutical Alliance is continuing the transition to a stand-alone organization including recruiting key leaders and ensuring all necessary operational supports are in place.
Working with the global executive search firm Odgers Berndtson, the pan-Canadian Pharmaceutical Alliance (pCPA) is recruiting a chief executive officer as it continues its transition to a stand-alone organization. The new CEO is expected to be in place this spring. Read the full update.